Hookipa Pharma Inc

NASDAQ:HOOK

1.22

-0.07 (-5.43%)

7:58:00 PM EDT: $1.23 +0.01 (+0.82%)

Market Cap (Intraday)	63.14M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.87 Million
Adjusted EPS	-$0.25

See more estimates

10-Day MA	$1.42
50-Day MA	$1.08
200-Day MA	$1.11

See more pivots

Hookipa Pharma Inc Stock, NASDAQ:HOOK

350 Fifth Avenue, 72nd Floor, Suite 7240, New York, New York 10118

United States of America

Phone: +43.1.890.6360

Number of Employees: 156

http://www.hookipapharma.com

Description

HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the bodyÃ¢â?¬â?¢s immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.